Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18923961rdf:typepubmed:Citationlld:pubmed
pubmed-article:18923961lifeskim:mentionsumls-concept:C0684336lld:lifeskim
pubmed-article:18923961lifeskim:mentionsumls-concept:C0229671lld:lifeskim
pubmed-article:18923961lifeskim:mentionsumls-concept:C2353566lld:lifeskim
pubmed-article:18923961pubmed:issue2lld:pubmed
pubmed-article:18923961pubmed:dateCreated2009-3-2lld:pubmed
pubmed-article:18923961pubmed:abstractTextEvidence suggests a relationship between peripheral Abeta and AD. We hypothesized that higher levels of serum Abeta(1-42) would be associated with memory impairment, thought to occur early in the disease, and rises in serum Abeta(1-40), which occur later, would be associated with impairment in non-memory measures.lld:pubmed
pubmed-article:18923961pubmed:languageenglld:pubmed
pubmed-article:18923961pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18923961pubmed:citationSubsetIMlld:pubmed
pubmed-article:18923961pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18923961pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18923961pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18923961pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18923961pubmed:statusMEDLINElld:pubmed
pubmed-article:18923961pubmed:monthMarlld:pubmed
pubmed-article:18923961pubmed:issn1744-4128lld:pubmed
pubmed-article:18923961pubmed:authorpubmed-author:CrawfordFiona...lld:pubmed
pubmed-article:18923961pubmed:authorpubmed-author:MullanMichael...lld:pubmed
pubmed-article:18923961pubmed:authorpubmed-author:ParisDanielDlld:pubmed
pubmed-article:18923961pubmed:authorpubmed-author:LuisCheryl...lld:pubmed
pubmed-article:18923961pubmed:authorpubmed-author:AbdullahLaila...lld:pubmed
pubmed-article:18923961pubmed:authorpubmed-author:Ait-GhezalaGh...lld:pubmed
pubmed-article:18923961pubmed:authorpubmed-author:QuadrosAmitaAlld:pubmed
pubmed-article:18923961pubmed:authorpubmed-author:MouzonBenoitBlld:pubmed
pubmed-article:18923961pubmed:authorpubmed-author:MullanMylesMlld:pubmed
pubmed-article:18923961pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18923961pubmed:volume16lld:pubmed
pubmed-article:18923961pubmed:ownerNLMlld:pubmed
pubmed-article:18923961pubmed:authorsCompleteYlld:pubmed
pubmed-article:18923961pubmed:pagination203-18lld:pubmed
pubmed-article:18923961pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:meshHeadingpubmed-meshheading:18923961...lld:pubmed
pubmed-article:18923961pubmed:year2009lld:pubmed
pubmed-article:18923961pubmed:articleTitleSerum beta-amyloid correlates with neuropsychological impairment.lld:pubmed
pubmed-article:18923961pubmed:affiliationRoskamp Institute, Sarasota, FL, USA. cluis@rfdn.orglld:pubmed
pubmed-article:18923961pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18923961pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed